What does the Rifinah (isoniazid + rifampicin) product information state about breastfeeding during treatment?

Rifinah’s rifampicin and isoniazid enter breast milk; breastfeeding is advised against unless a physician judges maternal benefit outweighs infant risk, and breastfed infants should be monitored for the theoretical risk of convulsions and neuropathy associated with vitamin B6 deficiency, with prophylactic pyridoxine considered for both mother and infant.